Accessibility settings

This paper is in the following e-collection/theme issue:

Mobile Health (mhealth) (5231) Consumer & Patient Education and Shared-Decision Making (1284)

Published on in Vol 19, No 7 (2017): July

iPhone displaying an ad about rosacea triggers

Direct-to-Consumer Promotion of Prescription Drugs on Mobile Devices: Content Analysis

Direct-to-Consumer Promotion of Prescription Drugs on Mobile Devices: Content Analysis

Authors of this article:

Kathryn J Aikin1 Author Orcid Image ;   Helen W Sullivan1 Author Orcid Image ;   Suzanne Dolina2 Author Orcid Image ;   Molly Lynch2 Author Orcid Image ;   Linda B Squiers2 Author Orcid Image
Article Authors Cited by (9) Tweetations (27) Metrics

Journals

  1. Kelly B, Rupert D, Aikin K, Sullivan H, Johnson M, Bann C, Mack N, Southwell B, West S, Parvanta S, Rabre A, Peinado S. Development and validation of prescription drug risk, efficacy, and benefit perception measures in the context of direct-to-consumer prescription drug advertising. Research in Social and Administrative Pharmacy 2021;17(5):942 View
  2. Alkazemi M, Van Stee S. Electronic direct-to-consumer advertising of pharmaceuticals: an assessment of textual and visual content of websites. Health Education Research 2020;35(2):134 View
  3. Giombi K, Thompson J, Wines C, Haughney R, Sullivan H, Betts K. A scoping review of empirical research on prescription drug promotion. Research in Social and Administrative Pharmacy 2023;19(6):859 View
  4. Flynn M, Lombana-Bermudez A, Palacios A. Latin America’s Digital Media Ecosystem: An Analysis of Prescription Drug Coverage and Diffusion. Journalism and Media 2024;5(4):1786 View
  5. Kravitz R. Health Care Ramifications of Pervasive Direct-to-Consumer Prescription Drug Advertising. Annual Review of Public Health 2026;47(1):479 View
  6. Wang I, Davis C, Forrest R, Cherla A, Siebert M, Cowden J, Walker S, Krishnamurti T, Bourgeois F, Woloshin S, Wagner A, Naci H. Navigating the Prescription Drug Information System. Clinical Pharmacology & Therapeutics 2026;120(4):855 View
  7. Lagoda N. Promotion of Medicines at Different Stages of the Drug Life Cycle. American Impact Review 2026;1(9):e2026076 View

Books/Policy Documents

  1. Weisenbach R. Institutionelle Korruption und Arzneimittelvertrieb. View
  2. Herold N. Institutionelle Korruption und Arzneimittelvertrieb. View